Clinical Trials Logo

Congenital FXIII Deficiency clinical trials

View clinical trials related to Congenital FXIII Deficiency.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT02670213 Enrolling by invitation - Clinical trials for Congenital Bleeding Disorder

A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan

Start date: March 16, 2016
Phase:
Study type: Observational

This study is conducted in Asia. Tha aim of this study is to investigate Safety and Effectiveness of NovoThirteen® (rFXIII) during treatment of congenital FXIII deficiency in Japan.